Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Advanced Biomed Inc. (ADVB) Balance Sheet

As of 2026-06-30 (10-K), Advanced Biomed Inc. (ADVB) reported total assets of $13.8M, total liabilities of $1.5M and shareholders' equity of $12.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $385535.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ADVBAdvanced Biomed Inc.Follow ADVB — free
Diagnostics & Research · Healthcare
—
Price chart with a free account
Market cap
5.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days
LineFY2025
Jun 25
FY2026
Jun 26
Latest
Jun 26
Trend
Cash and equivalents0.00.40.4
Current assets22.413.713.7
Total assets22.913.813.8
Current liabilities19.21.51.5
Total liabilities19.41.51.5
Shareholders' equity3.512.312.3

USD millions · SEC XBRL

Advanced Biomed Inc. — questions

How much cash does Advanced Biomed Inc. have?
$385535 in cash and cash equivalents as of 2026-06-30.
What are Advanced Biomed Inc.'s total assets?
$13.8M as of 2026-06-30.
What is Advanced Biomed Inc.'s shareholders' equity?
$12.3M as of 2026-06-30.

Every figure on this page comes from Advanced Biomed Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.